Evaluating the cost-effectiveness of levofloxacin therapy for household contacts of multidrug-resistant tuberculosis in VietnamResearch in context
Summary: Background: Multidrug-resistant tuberculosis (TB) threatens global TB control, on account of poor treatment outcomes, high treatment toxicity and costs. Recent trials demonstrated the effectiveness of six-months of levofloxacin (6Lfx) to prevent TB disease among high-risk contacts. However...
Saved in:
| Main Authors: | Tasnim Hasan, Nguyen Thu Anh, Nguyen Binh Hoa, Nguyen Viet Nhung, H. Manisha Yapa, Stephen M. Graham, Ben J. Marais, Guy B. Marks, Tom Lung, Greg J. Fox |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | The Lancet Regional Health. Western Pacific |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666606525002056 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Levofloxacin Derivatives as Potent Antibacterial Agents
by: Moshafi M. H., et al.
Published: (2017-04-01) -
mHealth application for improving treatment outcomes for patients with multidrug-resistant tuberculosis in Vietnam: an economic evaluation protocol for the V-SMART trial
by: Virginia Wiseman, et al.
Published: (2023-12-01) -
Synthesis a Number of Heterocyclic Compounds Derived From Levofloxacin
by: Ekram Abdullah Basheer, et al.
Published: (2023-02-01) -
Mapping residual malaria transmission in VietnamResearch in context
by: Michael A. McPhail, et al.
Published: (2025-04-01) -
Levofloxacin (Tavanic) in Complex Therapy of Tuberculosis
by: G. B. Sokolova, et al.
Published: (2020-05-01)